Workflow
Zevia (ZVIA) Reports Q3 Loss, Lags Revenue Estimates
ZVIAZevia(ZVIA) ZACKS·2024-11-06 14:16

Company Performance - Zevia reported a quarterly loss of 0.04pershare,betterthantheZacksConsensusEstimateofalossof0.04 per share, better than the Zacks Consensus Estimate of a loss of 0.11, and an improvement from a loss of 0.16pershareayearago,representinganearningssurpriseof63.640.16 per share a year ago, representing an earnings surprise of 63.64% [1] - The company posted revenues of 36.37 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 5.60%, and down from 43.09millionyear−over−year[2]−Overthelastfourquarters,ZeviahassurpassedconsensusEPSestimatestwotimesandtoppedconsensusrevenueestimatestwotimes[2]StockPerformance−Zeviashareshavedeclinedapproximately45.843.09 million year-over-year [2] - Over the last four quarters, Zevia has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Performance - Zevia shares have declined approximately 45.8% since the beginning of the year, contrasting with the S&P 500's gain of 21.2% [3] - The current consensus EPS estimate for the upcoming quarter is -0.10 on revenues of 40.28million,andforthecurrentfiscalyear,itis−40.28 million, and for the current fiscal year, it is -0.36 on revenues of $158.02 million [7] Industry Outlook - The Medical - Products industry, to which Zevia belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Zevia's stock performance [5]